Barbara Domayne Hayman

Investment Committee Member at Cambridge Enterprise Ltd.

Finance

Health Technology

Consumer Services

Profile

Barbara Domayne Hayman is currently an Investment Committee member at Cambridge Enterprise Ltd.
and the Chief Business Officer at Autifony Therapeutics Ltd.
She holds a doctorate degree from the University of Oxford.

Barbara Domayne Hayman active positions

Companies	Position	Start
Cambridge Enterprise Ltd. Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.	Investment Committee Member	-
Autifony Therapeutics Ltd. Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.	Corporate Officer/Principal	-

All active positions of Barbara Domayne Hayman

Training of Barbara Domayne Hayman

University of Oxford

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Barbara Domayne Hayman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Cambridge Enterprise Ltd. Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.	Finance
Autifony Therapeutics Ltd. Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.	Health Technology